Objectives. Percutaneous radiofrequency ablation (RFA) of the gasserian ganglion through the foramen ovale and the glossopharyngeal nerve at the jugular foramen is a classical approach to treating trigeminal neuralgia (TN) and glossopharyngeal neuralgia (GPN), respectively. However, it can be technically challenging with serious complications. We have thus developed a novel technique utilizing C-arm and computerized tomography (CT) guidance to block TN and GPN. Our goals were to describe a three-dimensional image-based technique to improve patient comfort and to decrease procedural time associated with needle guidance.
Introduction
Trigeminal neuralgia (TN) and glossopharyngeal neuralgia (GPN) are two debilitating forms of paroxysmal facial pain that affect the trigeminal nerve and glossopharyngeal nerve, respectively [1, 2] . Treatment of TN is multimodal, with medical management as the firstline therapy, including carbamazepine, oxcarbazepine, and others [2] . Approximately 30% of patients fail medical therapy, and these patients are candidates for more invasive interventions, such as microvascular decompression (MVD) or percutaneous trigeminal nerve ablation [3] [4] [5] . Percutaneous treatments include nerve ablation of gasserian ganglion at Meckel's cave through foramen ovale (FO) at the base of the skull with either ethanol, as initially described by Hartel in 1912, or radiofrequency thermocoagulation, as initially described by Sweet in 1974 . The success rate of these ablation procedures can be greater than 80% within three years following treatment [6, 7] , as reported in multiple large clinical trial series [4, 8, 9] . Radiofrequency ablation has the added benefit of being able to stimulate the nerve prior to ablation, which helps ensure that the desired distribution of the trigeminal nerve is targeted.
GPN is another paroxysmal debilitating pain condition featured by pain in the throat, pharynx, and ears [10] . The treatment algorithm is similar to that for TN, including medical management and nerve ablation procedures, such as percutaneous rhizotomy of the nerve through the jugular foramen (JF) via a lateral cervical approach. However, the incidence of GPN is much lower, roughly at 1% to 5% of TN; therefore, much less is known about its etiology and effective treatment modalities [2] .
Fluoroscopy remains the predominant method of image guidance for percutaneous procedures. However, skull base anatomy is complex, which often makes fluoroscopic guidance difficult. When an individual trigeminal sub-branch (e.g., V1 or V2) nerve block is desired, manipulation of the needle within Meckel's cave can be very painful to the patient and technically challenging, often necessitating general anesthesia and prolonged fluoroscopy times. Similarly, percutaneous rhizotomy of the glossopharyngeal nerve through the JF via a lateral cervical approach is the classic way to treat GPN. This lateral cervical JF approach can be complicated by injuries to the nearby vagus nerve, spinal accessory nerve, and the internal carotid artery.
Recent technological advances have been described to improve correct positioning of the needle for safer therapy, including transition from fluoroscopy to computerized tomography (CT) guidance, 3D navigation techniques, and electrophysiological recordings including evoked potential conformation [4, 6] . More recently, a CT-guided approach has been described to locate the foramen rotundum (FR) for better visualization during percutaneous V2 trigeminal nerve ablation procedures [11] .
In this article, we report a novel technique of flat-panel C-arm CT guidance to block the V3 branch via FO approach, the V2 branch via FR approach, and the glossopharyngeal nerve via peripheral styloid process (SP; distal to the jugular foramen) approach. With these techniques, we have conducted a study of 18 patients with classical TN, GPN, and atypical facial pain. Three representative classical neuralgia cases are presented in this article, along with detailed descriptions of the technique of flat-panel C-arm CT-guided radiofrequency ablative procedures involving V2, V3, and the glossopharyngeal nerve. The clinical outcomes and complications of these 18 patients are reported.
Methods
Patients were evaluated preoperatively, at which time the diagnosis was confirmed according to the International Headache Society (IHS) guidelines [12] . Magnetic resonance imaging or CT imaging of the skull base was performed to rule out potential secondary causes for TN including tumor and vascular compression. Post-herpetic neuralgia of the trigeminal nerve was excluded clinically.
On the day of procedure, written informed consent was obtained, and the patients were brought to the biplane fluoroscopy neuro-angiography suite with C-arm CT capability. Patients were under monitored anesthesia care using alfentanil and propofol as necessary during periods of needle placement. Atropine and external pacing was immediately available in case of bradycardia and hypotension, which may result from activation of the cardiotrigeminal reflex.
Patients were positioned supine on the biplane fluoroscopy table, with the neck mildly extended and the head gently secured with a soft strap. After a universal "time out" confirming the patient identity and procedure details, a preprocedure flat panel C-arm CT was then performed using an eight-second DR protocol on our Siemens Artis Zee neuroangiography system (Siemens HealthCare, Malvern, PA, USA). These images were then processed on a separate dedicated workstation. First, axial CT images were reviewed and the target located. A 5 mm tip 21G radiofrequency needle was used for the procedure. For V3, the FO was targeted; for V2, the FR in the pterygopalatine fossa was targeted, and for the glossopharyngeal nerve, the SP was targeted (5-10 mm posterior to the styloid process) (Figure 1 ) [13, 14] . We used Syngo iGuide software to reconfirm the skin entry point and the target. The software projects a needle path, which is reviewed so that the skin entry point can be adjusted to ensure that a safe path exists and that there is no bony impediment to advancement of the needle. Precise needle control is necessary to navigate the narrow passage between the zygomatic arch, the mandible, and the posterior wall of the maxillary sinus.
The lesion depth is measured on the processed CT images, and the needle is marked to this depth. Coordinates are then sent and the fluoroscopic C-arm is positioned so that a "bull's eye" approach can be taken with the needle to the desired target. As the needle approaches the target, discomfort in the appropriate Fluoroscopic C-Arm and CT-Guided Selective Radiofrequency Ablation nerve distribution is confirmed with the patient. With the needle in an appropriate position, the stylet is replaced with a probe and electrostimulation is performed to confirm the target. Nerve stimulation is performed, with the voltage slowly increased until stimulation can be confirmed. A voltage of less than 0.2-0.3 volts confirms adequate proximity to the nerve in question for successful treatment [15] . A subsequent injection of 0.5 to 1 mL 1% lidocaine to the target is given to achieve a dense sensory block in the corresponding dermatomal distribution, confirming the correct position of needle. Once positioning is confirmed, continuous radiofrequency ablation was performed for 60 seconds at 60 C, twice, with the needle tip turned 180 between cycles. Needle turning is performed to take advantage of the needle curvature to increase the treatment volume by creating overlapping spheres, creating a higher likelihood of delivering a successful treatment to the target nerve. Subsequently, a 2 mL mixture of 1 mL bupivacaine 0.25% and Decadron 10 mg is slowly and incrementally injected through the needle without resistance. Lastly, the needle was flushed with 1% lidocaine and withdrawn. Please note, in our study we have used a radiofrequency approach with a time and temperature combination that is within the range of typical pulsed (42 C limiting temperature Â 4 minutes) radiofrequency modulation and typical continuous (80-90 C limiting temperature Â 60-90 seconds) radiofrequency ablation. Our approach still belongs to the category of continuous radiofrequency ablation. Our approach simply elected to use the low-end (60 C) temperature for ablation purpose. The patient was subsequently transferred to the postprocedure recovery room, where vital signs were monitored for an additional two hours before being discharged home.
All skin entry points are chosen in a patient-specific fashion using iGuide software, but may be approximated as follows: For a V3 TN patient, the needle skin entry point is approximately 2 cm lateral to the corner of the mouth; for a V2 TN patient, the skin entry point is in the region of the intersection point of a vertical line drawn 1 cm lateral to outer canthus and the horizontal line of the base of the nose; for a GPN patient, the initial needle skin entry point is approximately 1 cm below the ipsilateral earlobe.
Results

Foramen Rotundum/V2 TN Patient
The opening to the FR lies within the pterygopalatine fossa ( Figure 1 ). We approached the FR from below the zygomatic arch to enter the pterygopalatine fossa through the pterygomaxillary fissure ( Figure 2) . Rarely, the bony anatomy may preclude a straightline path from this approach ( Figure 3 ). In this situation, a lateral approach maybe planned between the condylar and coronoid processes of the mandible ( Figure 3 ).
Patient 1: A 33-year-old otherwise healthy female presented to the pain clinic for classical V2 trigeminal neuralgia affecting her right-side cheek area for over a year. She described the pain located in her right maxillary premolars as a sharp shock that is 5-6/10 in severity, rising to 10/10 during mastication. The pain was intermittent, typically lasting for one to two minutes and subsiding when she stopped chewing. She had tried multiple medications including carbamazepine, oxcarbazepine, pregabalin, gabapentin, and topiramate, with no benefit. She was taking 4-5 oral oxycodoneacetaminophen 10-325 mg pills daily with mild to moderate benefits, but also accompanied by sedation and constipation. Physical exam showed normal sensation to touch and cold over the bilateral cheek and lower jaw areas. She was concerned with MVD surgery but was interested in a percutaneous radiofrequency ablation procedure in order to wean off her opioids completely. The patient underwent a fluoroscopic C-arm CT-guided rhizotomy of the right V2 nerve (Figure 2) . Following the procedure, the patient endorsed significant pain relief, with pain decreased from preprocedure numeric rating scale (NRS) score of 7-8/10 to postprocedure NRS of 0/10. The right side of her V2 cheek area was numb without V1 or V3 nerve involvement.
We followed up with her at one month, three months, and 12 months, and she had significant pain relief during the entire follow-up period. At her three-month follow-up visit, her pain had become much less severe to the extent that she was no longer using oral pain medications. She did have some mild persistent numbness in her right cheek and upper gum area, which she tolerated well.
Foramen Ovale/V3 TN Patient
The FO lies at the skull base adjacent to Meckel's cave and the gasserian ganglion ( Figure 1 ). The FO is easily recognized in the axial plane of a CT image, where it lies anterior and medial to the foramen spinosum. The two foramina together form the imprint of a high-heeled shoe ( Figure 1 ). The V3 branch of the trigeminal nerve exits through the FO and may be selectively targeted. The skin entry point is chosen below the zygomatic arch, and a straight-line trajectory is chosen to reach the FO (Figure 4) . Unlike the FR, the approach to the FO may be seen fluoroscopically.
Patient 2: An active 90-year-old gentleman with past medical history significant for hypertension and diabetes presented to our clinic with intermittent, shooting, stabbing right-sided low jaw facial pain that had lasted about 18 months. He was diagnosed with classical V3 TN after an extensive dental workup and treatment. When we saw him in clinic, he was having frequent daily attacks, exacerbated by brushing his teeth, touching his lower jaw, face, and variably with hair combing. He had no pain between the attacks. The patient was given a trial of carbamazepine, which did not provide any benefit. A trial of baclofen was helpful but was complicated by significant weakness in the leg, affecting his ability to ambulate. Therefore, percutaneous radiofrequency ablation was recommended.
The patient underwent successful fluoroscopic C-arm CT-guided ablation of the right V3 nerve (Figure 4 ). In the recovery room, the patient endorsed significant pain relief. Prior to the ablation, jaw and lower gum rubbing elicited 7-8/10 pain, but there was no pain with these triggers following the procedure. There was no nontarget numbness in the V1 or V2 sensory distribution.
Fluoroscopic C-Arm and CT-Guided Selective Radiofrequency Ablation
We evaluated the patient at one month, three months, and 12 months post-treatment, and he was found to have significant pain relief during the entire follow-up period. At his three-month follow-up visit, his pain was 60% to 70% improved, which lasted through 12 months. He was no longer taking baclofen, and he was back to his normal baseline activity. Postprocedural numbness in his lower jaw and gums was present but well tolerated.
Styloid Process/GPN Patient
The glossopharyngeal nerve passes through the pars nervosa of the jugular foramen, from which it exits the skull base and courses adjacent to the SP. We performed glossopharyngeal ablation by targeting the SP via a lateral cervical approach. A final needle position at or overshooting the styloid process posteriorly by 1-5 mm is ideal ( Figure 5 ) [13, 14] . Figure 2 A flat panel C-arm computerized tomography (CT) is performed. The C-arm CT is then used to select a needle path to the foramen rotundum using needle guidance software, and a lesion depth is calculated (A and B) . The needle is then positioned in a bull's eye approach targeting the selected depth, with a postpositioning CT performed to confirm the needle location prior to treatment, as depicted on this multiplanar reformatted CT image (C). A 3D reconstructed image displays the needle in position within the foramen rotundum (D).
Patient 3: A 22-year-old male with past medical history significant for anxiety and depression presented to our clinic with chronic pain in the left anterior neck region, lateral to the thyroid cartilage, as well as pain in the left side of his throat. There was no inciting event, and the pain duration was four months at presentation. The pain quality was described as squeezing and throbbing, and it was intermittent. His average pain numeric rating scale score was 5/10, with occasional exacerbations up to 10/10. The pain did radiate to the left ear and the pharynx. The pain was exacerbated by exercise, loud singing, stress, eating, and swallowing. A diagnosis of GPN was made. He subsequently had tried multiple medications including carbamazepine, pregabalin, and the tricyclic class of antidepressants with minimal benefits. He was therefore a candidate for percutaneous radiofrequency ablation.
The patient underwent successful ablation of the left glossopharyngeal nerve ( Figure 5 ). Following the procedure, the patient endorsed 100% pain relief. His preprocedure NRS score was 5-6/10, which reduced to 0/10 following the procedure. He left throat was completely numb after the procedure, which was well tolerated and expected. The pain relief persisted for 12 months, with NRS score minimal at 1-2/10 at one, three, and 12 months of follow-up. The patient reported mild numbness in left throat area at the three-month follow-up visit, which later resolved.
Atypical Facial Pain Patients
Thirteen additional atypical TN (8 V2 TN þ 5 V3 TN) and two atypical GPN patients (Table 1) were studied and treated, utilizing a similar technique as described above. NRS scores at pretreatment and at one month, three months, and 12 months postprocedure were recorded. The primary clinical outcome (successful pain relief with 50% or greater reduction in NRS) and secondary adverse clinical outcome (hematoma, facial numbness, masticatory weakness, corneal involvement, and difficulty swallowing) were compared and analyzed.
The technical success rate of needle placement at the target is 100%, confirmed by C-arm CT and electrostimulatory testing in awake patients. The clinical outcome in the atypical facial pain (AFP) group, however, showed much more variable results than the classical neuralgia patients as described above, with only five of 15 (33%) having sustained pain relief (NRS reduction > 50% up to 12 months), while in the other 10 of 15 (67%) patients we observed suboptimal response (NRS reduction < 50% and/or duration < 3 months). Complications encountered were mild and well tolerated, including mild to moderate facial numbness in the TN group (11/13, 85%), mild throat numbness in the GPN group (1/2, 50%), and mild masticatory weakness (2/13, 15%). There was no hematoma, corneal problem, or dysphagia as a result of treatment.
Discussion
Trigeminal neuralgia (TN) and glossopharyngeal neuralgia (GPN) are two challenging orofacial pain syndromes encountered by pain physicians. The incidence rate of TN has been reported as four to five people per 100,000 [4, 5] or even higher [6] . The pain might be Figure 3 An illustration of the lateral supramandibular approach to the foramen rotundum. Axial computerized tomography (CT) image demonstrating the planned approach and target depth (A). 3D reconstructed CT image demonstrates the relationship with the mandibular condyle and coronoid process (B).
Fluoroscopic C-Arm and CT-Guided Selective Radiofrequency Ablation
triggered by daily activities such as drinking, eating, or tooth brushing [16] . While TN is one of the most common causes of facial pain, GPN, on the other hand, is a rare cause of facial pain and is described by the IHS as a severe transient stabbing pain experienced in the ear, base of the tongue, tonsillar fossa, or beneath the angle of the jaw [17] . GPN attacks are often triggered by swallowing, talking, or coughing, with its incidence ranging from 0.2% to 1.3%, compared with TN, but with a similar clinical course and manifestation [18] .
Treatment of TN and GPN is multimodal, with medical management as firstline therapy, including carbamazepine, oxcarbazepine, gabapentin, Tricyclic antidepressant (TCAs), and others [2] . Approximately 30% of patients will fail medical therapy and are candidates for Figure 4 A BB marker is placed on the skin overlying the foramen ovale (black arrow) (A), and a flat panel C-arm computerized tomography (CT) is performed. The C-arm CT is then used to select a needle path to the foramen ovale using needle guidance software, and a lesion depth is calculated (B). The needle is then positioned in a bull's eye approach targeting the selected depth, with a postpositioning CT performed to confirm the needle location prior to treatment, as depicted on this multiplanar reformatted CT image (C). A 3D reconstructed image displays the needle in position within the foramen ovale (D).
interventions such as MVD, percutaneous ablation, gamma knife radiosurgery, and others [19] [20] [21] [22] [23] .
Percutaneous rhizotomy of trigeminal nerve divisions was first attempted by Hartel in the early 1900s and later by Sweet in the 1970s using radiofrequency. Hartel's technique describes a method of reaching the gasserian ganglion by passing a needle from the external side corner of the mouth and passing it cephalad and inward until the needle tip reached the temporal bone in front and to the outer side of the FO [24] . This allows the needle to be further advanced into the inner side of the FO to finally reach the gasserian ganglion [19] . In order for this procedure to have a high success rate, accurate placement of the needle and correct positioning of the electrode are crucial. Improper needle Figure 5 A BB marker is placed on the skin (A), and a flat panel C-arm computerized tomography (CT) is performed. The C-arm CT is then used to select a needle path using needle guidance software, and a lesion depth is calculated (B). The needle is then positioned in a bull's eye approach targeting the selected depth, with a postpositioning CT performed to confirm the needle location prior to treatment, as depicted on this multiplanar reformatted CT image abutting the styloid process (C). A 3D reconstructed image displays the needle in position adjacent to the styloid process (D).
Fluoroscopic C-Arm and CT-Guided Selective Radiofrequency Ablation placement can lead to catastrophic complications, including intracranial bleeding, seizure, or total spinal block [25, 26] . On the other hand, percutaneous rhizotomy of glossopharyngeal nerve at the jugular foramen via a lateral cervical approach is classic way to treat GPN. This approach can be complicated by injuries to the nearby vagus nerve, spinal accessory nerve, and internal carotid artery, leading to severe complications.
Visualization of needle placement is essential, has evolved considerably in the century after Hartel's first attempt, and includes 3D reconstruction, CT guidance, antidromically elicited evoked potentials monitoring, and others [19, [27] [28] [29] . These techniques have been useful in improving clinical outcome and have reduced perioperative injury of neurovascular structures. In spite of these improvements, the conventional FO approach has been associated with significant potential complications, especially for treating trigeminal V1/V2 sub-branch neuralgia. Clinically, after the needle is inside Meckel's cave, it is often difficult to differentiate the sub-branches from each other [30] . As a result, prolonged needle repositioning and adjustments are often required before individual sub-branch can be identified, thus significantly increasing the risk of dural puncture, infection, and intracranial bleeding.
Due to those concerns, for V2 TN patients, selective V2 block sometimes is done under C-arm fluoroscopy guidance at the pterygopalatine fossa, which is safer but is less effective for more proximal disease, and could be further complicated by simultaneous block of adjacent sphenopalatine ganglion and parasympathetic fibers [20] . Similarly, the conventional JF approach has been associated with significant complications, with potential injuries to nearby important nerves [31] [32] [33] . We have thus developed a novel combined flat panel C-arm CT and fluoroscopic guidance system approach to target V2 TN at the FR, V3 TN at the FO, and GPN at the SP.
For V2 TN patients, we started the project by first creating a CT image database of infrazygomatic needle insertion to FR in human skull specimens, as described in a previous paper [11] . The average diameter of the FR in adults is 3.0 6 0.4 mm, smaller than the FO (4.6 6 0.9 mm) [34] . Currently, there are few available fluoroscopy and/or CT images of infrazygomatic needle access of FR in humans. In our previous study, we found that in human skull specimens, the radiofrequency needle was able to directly access the FR via an infrazygomatic approach [11] . In addition, the curved radiofrequency needle can be directed and advanced into the FR canal with a gentle pressure. This finding has made it possible to target the FR, where V2 exits and is completely separated from V1 and V3. The needle puncture route is also away from oral, nasal, and pharyngeal spaces, thus minimizing risk of infection. Lastly, the needle path and FR canal orientation are not fully parallel/coaxial to each other, which protects Meckel's cave from the needle and further minimizes the risk of incidental dural puncture, intracranial infection, and bleeding. Taken together, the FR approach is feasible from an anatomical perspective, and we believe it is safer than the conventional FO approach when V2 trigeminal sub-branch nerve block is desired. This was further confirmed by this study, in which nine V2 TN patients were treated via the FR approach, with most sustained benefits observed in the classical V2 TN patient.
For V3 TN patients, we decided to target and ablate the nerve at a more peripheral location in FO rather than the classical gasserian ganglion location in Meckel's cave. The goal is to explore whether this approach can provide similar benefits but with less risk for nonspecific block of adjacent V1 and V2 sub-branches, and with fewer complications including dural puncture and intracranial bleeding. As shown in this study, the FO is easily recognized in the axial plane of a CT image, where it lies anterior and medial to the foramen spinosum. The V3 branch of the trigeminal nerve exits through the FO and can be selectively targeted at this location. Unlike FR, FO may often be visualized fluoroscopically. As shown in this paper, ablating the V3 branch at the FO is possible and resulted in sustained pain relief up to 12 months for our classical TN patient. In spite of its high selectivity, it remains to be determined whether ablating the V3 branch at the FO will provide similar long-term benefits (up to three years) as ablation at Meckel's cave (gasserian ganglion block) for classical TN patients. Preliminary data from our collaborators at Jiaxing Medical College Affiliated Hospital showed a similar long-term outcome at more than 24 months of follow-up visits (unpublished).
For GPN patients, our approach was to target the SP via a lateral cervical approach, rather than the classical JF approach (cranial nerves IX, X, and XI pass through together at the level of JF). The classical JF approach can be complicated by injuries to the nearby vagus nerve, spinal accessory nerve, and the internal carotid artery. At the SP level, cranial nerves IX, X, and XI have sufficiently separated from each other, with nerve IX being most adjacent to the distal part of SP. With this approach, we intercept the IX nerve as it passes through the pars nervosa of the JF and exits the skull base, coursing adjacent to the styloid process. We accomplish this block by targeting the styloid process via a lateral cervical approach. This allows us to avoid unwanted complications such as damage to neurovascular tissue and dural folds. Our study found that ablating the cranial nerve IX via the SP approach is possible, safe, and may provide up to 12 months of sustained pain relief for the classical GPN patient.
Lastly, our atypical facial pain patient's course was not as successful but did mirror the results from previous studies. AFP is a complex diagnosis, presenting with some similar features with trigeminal TN, but often with longer duration (minutes, hours, or continuous) and of dull, burning, aching, burning, sharp, squeezing, or crushing quality, and often without imaging or lab aberrations suggesting an underlying cause. In contrast to our success with classical TN and GPN, our data from the AFP group are less effective and showed much more variable results, with only five of 15 (33%) having good immediate and sustained pain relief (NRS reduction > 50% up to 12 months), while in the other 10 (67%) patients we only observed a suboptimal response (NRS reduction < 50% and/or duration < 3 months). However, these results are consistent with what is found in the literature [35] [36] [37] . This is also consistent with our own institutional study from the 1970s for AFP patients [38] . Attempting to treat AFP too aggressively, due to the known low success rate, can result in undesired lesions of adjacent trigeminal branches during percutaneous therapy.
CT-guided TN or GPN blocks are not commonly utilized in clinical practice. Other CT guidance techniques for other technically challenging pain blocks, such as celiac plexus block, have shown improved efficacy and lower side effects [39] . Candido et al. published a case report on using CT guidance for a gasserian ganglion block for a patient with V1 TN secondary to herpes simplex type I [40] . The patient had remarkable pain relief that was sustained beyond a six-month period with no adverse effects. Many pain medicine physicians and neurosurgeons use standard fluoroscopic guidance due to unfamiliarity with using CT guidance. Reasons offered include potential scheduling difficulty, additional radiation, and prolonged procedural time [28] . Our study demonstrates that a novel CT-guided approach can be a good alternative to the classical fluoroscopic approach when an isolated V2 branch or V3 branch block is desired, and when a safer and effective GP nerve block is needed.
In our study, we have used radiofrequency ablation at 60 C limiting temperature over 60 seconds for two cycles. This radiofrequency approach uses a time and temperature that are between typical pulsed radiofrequency modulation (40 C) and continuous radiofrequency ablation (80 C or above) times and temperatures. We found that using our RF time and temperature protocol we were able to ablate the nerves enough to cause significant relief without completely damaging the nerve, causing profound numbness and complete loss of motor function, as with continuous RF, or getting a low success rate, as with pulsed RF. Our classical facial pain patient was found to have significant pain relief during the entire follow-up period, with only mild numbness and weakness that was tolerable. Using an intermediate heat lesion, as we have done in our study, appears to cause selective destruction of the pain carrying A delta and C fibers while sparing the larger A beta and motor fibers [7] for some patients, though further studies are needed to confirm the findings. We cannot conclude yet, with our limited data, that 60 radiofrequency ablation is motor sparing.
Limitations
This study is limited by its small sample size and nonrandomized study; however, the following steps were taken to maximally minimize potential bias: 1) all procedures were performed by the same physician team; 2) primary outcome (pain score) and secondary outcome (numbness, motor dysfunction, and hematoma) have been followed up both short term and long term, up to one year, which may reduce the probability of the placebo effect as the placebo effect in general decreases over time [41] . An additional limitation is the inability to parse a regression to the mean effect from the measured response, which is an inherent limitation of our study design.
Conclusions
We present a novel technique utilizing C-arm CT and fluoroscopic-guided radiofrequency ablation of chronic facial pain. Using this method, we have had 100% technical success with needle guidance to previously difficult locations, specifically the foramen rotundum and the styloid process. Such accuracy with needle placement might help enable future advancements in the radiofrequency ablation algorithm so that more durable and consistent effects can be attained, minimizing uncertainty with respect to needle placement as a confounder. This technique can be effective, with potential to provide good clinical results.
